Oral Anticoagulant Drug Interactions with Statins: Case Report of Fluvastatin and Review of the Literature

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pharmacotherapy

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1592/phco.24.2.285.33137PMID 14998226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles.

  2000cited by this paper
• Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians.

  2000cited by this paper
• Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarin

  1999cited by this paper
• Venous thromboembolism.

  1999cited by this paper
• The Effect of Converting from Pravastatin to Simvastatin on the Pharmacodynamics of Warfarin

  1999cited by this paper
• Population pharmacokinetic‐pharmacodynamic analysis of fluindione in patients

  1998cited by this paper
• Potential Warfarin—Fluvastatin Interaction

  1997cited by this paper
• Atorvastatin Does Not Alter the Anticoagulant Activity of Warfarin

  1997cited by this paper
• Pravastatin: interaction with oral anticoagulant?

  1996cited by this paper
• Potential Interaction between Warfarin and Fluvastatin

  1996cited by this paper
• Simvastatin-oral anticoagulant interaction.

  1996cited by this paper
• In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

  1996cited by this paper
• ONE HUNDRED YEARS AGO

  1996cited by this paper
• Lovastatin during warfarin therapy resulting in bleeding.

  1995cited by this paper
• The interaction of lovastatin and warfarin.

  1992cited by this paper
• Simvastatin during warfarin therapy in hyperlipoproteinaemia.

  1992cited by this paper
• Lovastatin. Warfarin interaction.

  1990cited by this paper
• Pharmacokinetics of the enantiomers of acenocoumarol in man.

  1981cited by this paper

• Construction of warfarin population pharmacokinetics and pharmacodynamics model in Han population based on Bayesian method

  2024cites this paper
• Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices

  2022cites this paper
• Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism—From Modern Recommendations to Clinical Application

  2022cites this paper
• A dose‐related positive effect of inhaled simvastatin‐loaded PLGA nanoparticles on paraquat‐induced pulmonary fibrosis in rats

  2022cites this paper
• Investigation of Atorvastatin interaction with human serum albumin: evaluation of pH effect and competitive binding with warfarin

  2022cites this paper
• Phytomedicines: Synergistic and antagonistic phytometabolites-drug interactions

  2021cites this paper
• Top 10 Prescribed Drugs: What Do Dental Clinicians Need To Know

  2021cites this paper
• The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis

  2020cites this paper
• Riesgo-beneficio de la retirada de estatinas en cuidados paliativos: revisión sistemática de la literatura

  2020cites this paper
• Comparison of Two Different Techniques Of Warfarin Dosing Determination - A Chemometrics Study

  2019cites this paper
• Influence of Concomitant Treatments under Anticoagulants and Statins in Detecting Signals of Adverse Drug Reactions

  2019cites this paper
• Safety assessment of concurrent statin treatment and evaluation of drug interactions in China

  2018cites this paper
• Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore

  2018influential citation
• Mortality and Associated Morbidities Following Traumatic Brain Injury in Older Medicare Statin Users

  2018cites this paper
• THE GAP BETWEEN ECONOMIC EVALUATIONS AND CLINICAL PRACTICE: A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON DABIGATRAN FOR ATRIAL FIBRILLATION

  2018cites this paper
• A Race‐Specific Interaction Between Vitamin K Status and Statin Use During Warfarin Therapy Initiation

  2017cites this paper
• R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies.

  2017cites this paper
• Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.

  2017cites this paper
• Old and new oral anticoagulants: Food, herbal medicines and drug interactions.

  2017cites this paper
• Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

  2016cites this paper
• Mechanism of Drug-Drug Interactions Between Warfarin and Statins.

  2016cites this paper
• Statin Selection in Qatar Based on Multi-indication Pharmacotherapeutic Multi-criteria Scoring Model, and Clinician Preference.

  2015cites this paper
• PharmGKB summary: very important pharmacogene information for CYP4F2

  2015cites this paper
• Prediction of sensitivity to warfarin based on VKORC1 and CYP2C9 polymorphisms in patients from different places in Colombia.

  2015cites this paper
• Potential drug interactions with statins: Estonian register-based study

  2015cites this paper
• Co-prescribing of Warfarin with Statins and Proton Pump Inhibitors in Elderly Australians

  2014influential citation
• Potential statin-drug interactions: prevalence and clinical significance

  2014cites this paper
• Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin

  2014cites this paper
• Interacciones medicamentosas de agentes hipolipemiantes: aproximación para establecer y valorar su relevancia clínica. Revisión estructurada

  2013cites this paper
• Co‐medication of pravastatin and paroxetine—A categorical study

  2013cites this paper
• Safety of statins

  2013cites this paper
• Towards optimal dosing of coumarin derivatives: the role of pharmacogenetics

  2013cites this paper
• Drugs for Elevated Low-Density Lipoprotein Cholesterol

  2013cites this paper
• Addressing key questions with statin therapy.

  2012cites this paper
• Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin.

  2012cites this paper
• Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose

  2012cites this paper
• Meeting new challenges with antiplatelet therapy in primary care.

  2012cites this paper
• Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more

  2012cites this paper
• Statin Drug Interactions in Patients with Comorbidities and on Multiple Medications

  2012cites this paper
• Drug Interactions Involving Warfarin: Practice Tool and Practical Management Tips

  2011cites this paper
• Drug and dietary interactions of warfarin and novel oral anticoagulants: an update

  2011cites this paper
• Severe INR elevation related to duloxetine use: a case report.

  2011cites this paper
• Thromboembolic Events in the Perioperative Period

  2011cites this paper
• Cytochrome P450-mediated cardiovascular drug interactions

  2011cites this paper
• Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk.

  2010cites this paper
• Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery

  2010cites this paper
• CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant

  2009cites this paper
• Statins and stroke.

  2008cites this paper
• Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin

  2008cites this paper
• Atrial fibrillation in chronic non-cardiac disease: where do we stand?

  2008cites this paper
• Probable Warfarin–Simvastatin Interaction

  2007cites this paper
• Cytochrome P450: another player in the myocardial infarction game?

  2007cites this paper
• Drugs for Elevated LDL cholesterol

  2007cites this paper
• Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?

  2007cites this paper
• Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy

  2007cites this paper
• Drug interactions with lipid‐lowering drugs: Mechanisms and clinical relevance

  2006cites this paper
• Risk of Impaired Coagulation in Warfarin Patients Ascending to Altitude (>2400 m)

  2006cites this paper
• The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose

  2006cites this paper
• Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions

  2006cites this paper
• ERSPECTIVES IN CLINICAL HARMACOLOGY rug interactions with lipid-lowering rugs : Mechanisms and clinical relevance

  2006cites this paper
• Effects of Acid and Lactone Forms of Eight HMG-CoA Reductase Inhibitors on CYP-Mediated Metabolism and MDR1-Mediated Transport

  2005cites this paper
• Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.

  2005cites this paper
• Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis

  2005cites this paper
• Fluvastatin: efficacy and safety in reducing cardiac events

  2005cites this paper
• Low Potential for Interactions Between Melagatran/Ximelagatran and Other Drugs, Food, or Alcohol

  2005cites this paper
• Rosuvastatin for the Treatment of Hypercholesterolemia

  2005cites this paper
• Rosuvastatin-acenocoumarol interaction.

  2005cites this paper